Cumberland Pharmaceuticals Company Insiders

Cumberland Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.0564) % which means that it has lost $0.0564 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3607) %, meaning that it created substantial loss on money invested by shareholders. Cumberland Pharmaceuticals' management efficiency ratios could be used to measure how well Cumberland Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.12 in 2025. Return On Capital Employed is likely to drop to -0.13 in 2025. At this time, Cumberland Pharmaceuticals' Total Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 18.7 M in 2025, whereas Total Assets are likely to drop slightly above 88.1 M in 2025. Common Stock Shares Outstanding is likely to rise to about 13.5 M in 2025, despite the fact that Net Loss is likely to grow to (4.8 M).

Cumberland Pharmaceuticals Workforce Comparison

Cumberland Pharmaceuticals Profit Margins

The company has Profit Margin (PM) of (0.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.19) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.19.

Cumberland Pharmaceuticals Insider Trading History

Cumberland Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Cumberland Pharmaceuticals often depends on how effective the management is. Cumberland Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cumberland management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cumberland management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Cumberland Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cumberland Pharmaceuticals. Check Cumberland Pharmaceuticals' Beneish M Score to see the likelihood of Cumberland Pharmaceuticals' management manipulating its earnings.

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.